0001213900-17-012230.txt : 20171116
0001213900-17-012230.hdr.sgml : 20171116
20171116163059
ACCESSION NUMBER: 0001213900-17-012230
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171114
FILED AS OF DATE: 20171116
DATE AS OF CHANGE: 20171116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zarrabian Saiid
CENTRAL INDEX KEY: 0001495521
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37823
FILM NUMBER: 171208347
MAIL ADDRESS:
STREET 1: P.O. BOX 675765
CITY: RANCHO SANTA FE
STATE: CA
ZIP: 92067
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DelMar Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001498382
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 990360497
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: SUITE 720-999 WEST BROADWAY
CITY: VANCOUVER
STATE: A1
ZIP: V5Z 1K5
BUSINESS PHONE: (604) 629-5989
MAIL ADDRESS:
STREET 1: SUITE 720-999 WEST BROADWAY
CITY: VANCOUVER
STATE: A1
ZIP: V5Z 1K5
FORMER COMPANY:
FORMER CONFORMED NAME: Berry Only Inc.
DATE OF NAME CHANGE: 20100805
4
1
f4111417zarrabian_delmar.xml
OWNERSHIP DOCUMENT
X0306
4
2017-11-14
0
0001498382
DelMar Pharmaceuticals, Inc.
DMPI
0001495521
Zarrabian Saiid
SUITE 720-999 WEST BROADWAY
VANCOUVER
A1
V5Z 1K5
BRITISH COLUMBIA, CANADA
1
1
0
0
Interim CEO
Common Stock
2017-11-14
4
P
0
55000
0.82
A
55000
D
Common Stock
2017-11-14
4
P
0
5900
0.84
A
5900
I
By Child
This transaction was executed in multiple trades at prices ranging from $0.8015 to $0.8385. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $0.8298 to $0.84. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Saiid Zarrabian
2017-11-15